Results 201 to 210 of about 38,328 (233)
Some of the next articles are maybe not open access.
Progressive Systemic Sclerosis (Scleroderma)
Australasian Annals of Medicine, 1970SummarySixteen cases of progressive systemic sclerosis (PSS) were studied in a large general hospital in Singapore from 1957 to 1967. Thirteen were Chinese and 3 Malays. The majority were middle‐aged housewives and half of the cases were seen less than six months after onset.
C H, Tay, O T, Khoo
openaire +2 more sources
Systemic and localized scleroderma
Clinics in Dermatology, 2006Sclerosing conditions of the skin are manifested by a full spectrum of presentations that includes skin-limited forms as well as those which can involve internal organs and result in death. At this point, we are just beginning to understand the mechanisms of tissue fibrosis, and it is likely that the fibrotic processes are a heterogeneous group of ...
Lorinda, Chung +3 more
openaire +2 more sources
Localized and systemic scleroderma
Seminars in Cutaneous Medicine and Surgery, 2001Scleroderma is a broad term encompassing both localized and systemic sclerosis. Localized scleroderma is a cutaneous limited fibrosis that manifests as plaque morphea, generalized morphea, linear scleroderma, and deep morphea. Systemic scleroderma (sclerosis) can manifest as either limited or diffuse disease.
A, Hawk, J C, English
openaire +2 more sources
Progressive Systemic Sclerosis (Scleroderma)
New England Journal of Medicine, 1953THE skin manifestations of scleroderma have long been recognized and adequately described. These features are usually identified readily, particularly in the later phases of the disease when the spectacular, hardened, bound-down, wrinkleless appearance of the skin is so characteristic as to supply a descriptive name for the illness. This term refers to
P M, BEIGELMAN, F, GOLDNER, T B, BAYLES
openaire +3 more sources
HLA in Systemic Scleroderma (PSS) and Familial Scleroderma
The Journal of Dermatology, 1991AbstractHLA in systemic scleroderma (PSS), including three familial cases, is reported. Three families in which one sister developed PSS and another sister suffered from either PSS (family 1), mixed connective tissue disease (MCTD) (family 2), or Sjögren's syndrome (SjS) (family 3) were described.
T, Sasaki, K, Denpo, H, Ono, H, Nakajima
openaire +2 more sources
La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris, 1984
The etiology of systemic scleroderma is still unknown. This disease is well individualized by its usual forms, i.e. acrosclerosis and diffuse form, whose features and prognosis differ. The description of new entities has generated further interest, particularly through a different diagnostic and therapeutic approach. No specific biologic or immunologic
openaire +1 more source
The etiology of systemic scleroderma is still unknown. This disease is well individualized by its usual forms, i.e. acrosclerosis and diffuse form, whose features and prognosis differ. The description of new entities has generated further interest, particularly through a different diagnostic and therapeutic approach. No specific biologic or immunologic
openaire +1 more source
Systemic Scleroderma and Pregnancy
1999Abstract Young women with systemic scleroderma often ask me if it is okay to get pregnant. The answer is that it depends on several factors: the stage of the disease, the medications that are required to control the disease, and the risks that people are willing to take in order to have a child.
openaire +1 more source
Advanced Emergency Nursing Journal, 2007
Stacey Harris-Akers, Elda G. Ramirez
openaire +1 more source
Stacey Harris-Akers, Elda G. Ramirez
openaire +1 more source